Diagnostic test approval at premier academic cancer center in New York: OGM-based testing is now approved for clinical use in genetic disorders and hematologic malignancies at URochester Medicine ...

Marquis Who's Who announces the inclusion of Monib A. Zirvi, MD, PhD, in its biographical volumes in recognition of his more ...

Marquis Who's Who announces the inclusion of Monib A. Zirvi, MD, PhD, in its biographical volumes in recognition of his more than two decades of ...

An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from ...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, ...

The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation. BlossomHill Therapeutics is a ...

According to MarketsandMarkets™, the Sepsis Diagnostics Market is projected to reach USD 1.22 billion by 2031 from USD 0.83 ...

Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and ...

According to MarketsandMarkets, the Sepsis Diagnostics Market is projected to reach USD 1.22 billion by 2031 from USD 0.83 billion in 2026, at a ...

Expanded, pan-ethnic carrier screening is gaining traction, driven by cheaper sequencing, AI interpretation and digital counseling, with opportunities in clinics, fertility care and consumer ...

Researchers have captured the moment two DNA molecules zip together, overcoming their identical negative charges to pair up ...